Expression of sialyl-Tn, Tn and T antigens in primary liver cancer

Pathology International

Volumn 49, Issue 4, 1999, Pages 325-331

  Sasaki, Motoko ^a,b   Yamato, Taro ^a   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cholangiocarcinoma; Combined hepatocellular cholangiocellular carcinoma; Mucin, sialyl Tn; T antigen; Tn

Indexed keywords

MUCIN LIKE CARCINOMA ASSOCIATED ANTIGEN; SIALIC ACID DERIVATIVE; SIALYL TN ANTIGEN; T ANTIGEN; TN ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BILE DUCT CARCINOMA; CANCER INVASION; CLINICAL ARTICLE; GLYCOSYLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; ANTIGENS, VIRAL, TUMOR; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MUCINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032589521     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.1999.00867.x     Document Type: Article

References (35)

1. 1 Neutra MR, Foretner JF. Gastrointestinal mucus: Synthesis, secretion, and function. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. Raven Press, New York, 1987; 975-1009.
2. 2 Pigny P, Guyonnet-Duperat V, Hill AS et al. Human mucin genes assigned to 11p15.5: Identification and organization of a cluster of genes. Genomics 1996; 38: 340-352.
3. 3 Kim YS, Gum JR. Diversity of mucin genes, structure, function, and expression. Gastroenterology 1995; 109: 999-1013.
4. 4 Yonezawa S, Sato E. Expression of mucin antigens in human cancers and relationship with malignancy potential. Pathol. Int. 1997; 47: 813-830.
5. 5 Ho SB, Niehans GA, Lyftogt C et al. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res. 1993; 53: 641-651.
6. 6 Sasaki M, Nakanuma Y, Kim YS. Characterization of apomucin expression in intrahepatic cholangiocarcinoma and their precursor lesions: An immunohistochemical study. Hepatology 1996; 24: 1074-1078.
7. 7 Izkowitz SH, Yuan M, Montgomery CK et al. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res. 1989; 49: 197-204.
8. 8 Springer GF. T and Tn, general carcinoma autoantigens. Science 1984; 224: 11-15.
9. 9 Tashiro Y, Yonezawa S, Kim YS, Sato E. Immunohistochemical study of mucin carbohydrate and core proteins in human ovarian tumors. Hum. Pathol. 1994; 25: 364-372.
10. 10 Iwata H, Itzkowitz SH, Werther JL et al. Expression of sialosyl-Tn in intestinal type cancer cells of human gastric cancers. Acta Pathol. Jpn. 1993; 43: 646-653.
11. 11 Kjeldsen T, Clausen H, Hirohashi S, Ogata T, Iijima H, Hakomori S. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2 → 6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res. 1988; 48: 2214-2220.
12. 12 Izkowitz SH, Bloom EJ, Kokal WA, Modin G, Hakomori S, Kim YS. Sialosyl-Tn: A novel mucin antigen association with prognosis in colorectal cancer patients. Cancer 1990; 66: 1960-1966.
13. 13 Ma XC, Terata N, Kodama M, Jancic S, Hosokawa Y, Hattori T. Expression of sialyl-Tn antigen is correlated with survival time of patients with gastric carcinoma. Eur J. Cancer Part A 1993; 29: 1820-1823.
14. 14 Yamashita Y, Chung YS, Horie R, Kannnagi R, Sowa M. Alterations in gastric mucin with malignant transformation: Novel pathway for mucin synthesis. J. Natl Cancer Inst. 1995; 87: 441-449.
15. 15 Terasawa K, Furumoto H, Kamada M, Aono T. Expression of Tn and sialyl-Tn antigens in the neoplastic transformation of uterine cervical epithelial cells. Cancer Res. 1996; 56: 2229-2232.
16. 16 Bresalier RS, Ho SB, Schoeppner HL et al. Enhanced siatylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology 1996; 110: 1354-1367.
17. 17 Nakanuma Y, Terada T, Tanaka Y, Ohta G. Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma. Virchows Arch. A Pathol. Anat. Histopathol. 1985; 406: 45-58.
18. 18 Nakanuma Y, Sasaki M, Terada T, Harada K. Intrahepatic peribiliary glands of humans. II: Pathological spectrum. J. Gastroenterol. Hepatol. 1994; 9: 80-86.
19. 19 Wee A, Ludwig J, Cobbey RJ, LaRusso NF, Wiesner RH. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum. Pathol. 1985; 16: 719-726.
20. 20 Belamaric J. Intrahepatic bile duct carcinoma and C. sinensis infection in Hong Kong. Cancer 1972; 31: 468-473.
21. 21 Honda N, Cobb C, Lechago J. Bile duct carcinoma associated with multiple von Meyenburg complexes in the liver. Hum. Pathol. 1986; 17: 1287-1290.
22. 22 Rubel LR, Usn CMC, Ishak KG. Thorotrast-associated cholangiocarcinoma: An epidemiologic and clinicopathologic study. Cancer 1982; 50: 1408-1415.
23. 23 Terada T, Kida T, Nakanuma Y, Kurumaya H, Doishita K, Takayanagi N. Intrahepatic cholangiocarcinomas associated with non-biliary cirrhosis. J. Clin. Gastroenterol. 1994; 18: 335-342.
24. 24 Tomimatsu M, Ishiguro N, Taniai M et al. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocellular carcinoma) in Japan. Cancer 1993; 72: 683-688.
25. 25 Ferlan-Marolt V, Markovic S. Clinicopathologic manifestation of primary liver carcinoma (PLC) in liver cirrhosis. Cancer Detect. Prev. 1986; 9: 459-493.
26. 26 Sasaki M, Nakanuma Y, Ho SB, Kim YS. Cholangiocarcinoma arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles. Am. J. Clin. Pathol. 1998; 109: 302-308.
27. 27 Terada T, Nakanuma Y. Pancreatic lipase is a useful phenotypic marker of intrahepatic large and septal bile ducts, peribiliary glands, and their malignant counterparts. Mod. Pathol. 1993; 6: 419-426.
28. 28 Yamashita K, Yonezawa S, Tanaka S et al. Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma. Int. J. Cancer 1993; 55: 82-91.
29. 29 Okuda K, Kubo Y, Okazaki N et al. Clinical aspects of intrahepatic cholangiocarcinoma including hilar carcinoma. Cancer 1977; 39: 232-246.
30. 30 Hsu SM, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled (PAP) procedures. J. Histochem. Cytochem. 1981; 29: 577-580.
31. 31 Torii T, Takahashi A, Dohi K. Statistics for Medicine and Biology. Tokyo University Press, Tokyo, 1973 (in Japanese).
32. 32 Sasaki M, Morita T, Hoso M, Nakanuma Y, Tanimura H. Carcinoembryonic antigen and blood group-related carbohydrate antigens in glycoproteins in human bile in hepatolithiasis. Hepatology 1996; 23: 258-263.
33. 33 Otsuka K, Mizuno M, Kagawa K, Kinochita K, Ohkuma S. Presence of a Vicia unijuga lectin-binding (Vgu) glycoprotein with Thomsen-Friedreich activity and Vgu glycoproteins in human primary hepatocellular carcinoma. Int. J. Biochem. 1992; 24: 1407-1419.
34. 34 De Bolos C, Garrido M, Real FX. MUC6 apomucin shows a distinct normal tissue distribution that correlated with Lewis antigen expression in the human stomach. Gastroenterology 1995; 109: 723-734.
35. 35 Okuda K. Clinical presentation and natural history of hepatocellular carcinoma and other liver cancers. In: Okuda K, Tabor E, eds. Liver Cancer. Churchill Livingstone, New York, 1997; 1-12.